abstract: Developmental abnormalities of human embryos can be visualized in utero using embryoscopy. Our previous embryoscopic and genetic evaluations detected developmental abnormalities in the majority of both euploid (74%) and aneuploid or polyploid (90%) miscarriages. Since we found the pattern of morphological changes to be similar in euploid and non-euploid embryos, we proposed that lethal submicroscopic changes, not detected by standard chromosome testing, may be responsible for miscarriage of euploid embryos. Whole genome oligo and bacterial artificial chromosome array comparative genome hybridization (CGH) was used to screen for submicroscopic chromosomal changes (DNA copy number variants or CNVs) in 17 euploid embryonic miscarriages, with a range of developmental abnormalities documented by embryoscopy. The CNV breakpoints were refined using a custom array (Agilent) with high resolution coverage of the CNVs. Six unique CNVs, previously not reported, were identified in 5 of the 17 embryos (29% of all cases or 50% of cases studied with higher resolution arrays). All six unique CNVs were ,250 kb in size. On the basis of parental array CGH analysis, a de novo origin of a CNV was determined for one embryo (at 13q32.1) and suspected for another (at 10p15.3). Three CNVs, at Xq28, 1q25.3 and 7p14.3, were inherited and a CNV at 17p13.1 was of unknown origin. The genes contained within these unique CNVs will be discussed, with specific reference to rearrangements of syntaxin and tryptophan-aspartic acid (WD) repeat genes. Our report describes for the first time, de novo and inherited unique CNVs in euploid human embryos with specific developmental defects.
Introduction
Approximately 15% of all clinically recognized pregnancies spontaneously end in miscarriage, mostly during embryonic development, defined as up to 10 weeks of gestation (Goddijn and Leschot, 2000) . Clinical information on the miscarriages is routinely obtained by pathology and cytogenetic analysis of the miscarriage tissue.
Pathology examination is often challenging because intact specimens are obtained in only 50% of cases, primarily due to mechanical trauma, occurring either during spontaneous passage or instrumental evacuation (Kalousek, 2001) . Specimens are classified into three groups, based on morphology: (a) normal embryos showing good correlation between their crown-rump length and developmental stage; (b) embryos with focal defects showing localized abnormal development for their estimated developmental age; and (c) embryos with growth disorganization (Poland et al., 1981) .
The recent development and application of embryoscopy allows the morphological evaluation of the majority (.85%) of early miscarriages in utero, prior to mechanical trauma (Philipp et al., 2003) . Using embryoscopy, we established that the majority of human miscarriages (.70%) have abnormal morphology. Cytogenetic abnormalities were found in 83% of cases with localized external defects and 70% of cases with growth disorganization. Conversely, 17 and 30% of cases, respectively, were found to have euploid cytogenetic results, thus, the cause of abnormal morphology in euploid embryos remains unexplained. Since similar morphological defects were found in both euploid and non-euploid embryos, the possibility was raised that submicroscopic chromosome changes could be present in euploid embryos and result in abnormal embryogenesis (Philipp et al., 2003) .
The development of array comparative genomic hybridization (CGH), which screens the genome for submicroscopic chromosomal changes , has provided the opportunity to search for 'miscarriage genes'. So far, targeted and low resolution (1 Mb) whole genome arrays have been predominantly used to investigate approximately 150 miscarriages worldwide for the presence of submicroscopic chromosome changes (Schaeffer et al., 2004; Benkhalifa et al., 2005; Shimokawa et al., 2006; Zhang et al., 2009) . Submicroscopic changes were found in 4-13% of euploid miscarriages (Schaeffer et al., 2004; Shimokawa et al., 2006; Zhang et al., 2009 ) and 8% of non-euploid miscarriages (Schaeffer et al., 2004) . In addition, larger chromosomal changes missed by conventional cytogenetic analyses were found in 2-5% of miscarriages [mosaic trisomy 20 (Schaeffer et al., 2004) and deletion of 13q32.3 (Shimokawa et al., 2006) ]. Array CGH of miscarriages that failed to grow in culture (Benkhalifa et al., 2005; Zhang et al., 2009 ) revealed chromosomal abnormalities in 29-58% of cases, some of which (6%) were submicroscopic. Although these initial studies are important for determining the prevalence and type of submicroscopic chromosome changes in miscarriages that can be identified by array CGH, they all lacked parental studies to determine whether the changes were inherited or de novo. In addition, in most of the cases the results were described by the chromosomal bands involved, rather than the specific genomic sites of submicroscopic gains or losses, or their genetic content. Finally, correlation of submicroscopic findings with embryonic morphology was not provided.
Since these initial studies, higher resolution whole genome array CGH has become available (Edelmann and Hirschhorn, 2009 ). In addition, our knowledge about the human genome and its copy number variability in normal individuals expanded significantly (Lee et al., 2007) . However, whole genome screening methods accompanied by parental analysis have not yet been applied to the study of the genome in human miscarriages. Using whole genome and custom array CGH, this study was designed to screen for copy number variants (CNVs) which could account for euploid embryonic miscarriages, with abnormal morphology detected by embryoscopy.
Materials and Methods

Embryoscopy
Seventeen euploid embryonic miscarriages, defined as a crown-rump length between 4 and 30 mm without cardiac activity on transvaginal ultrasonography, were included in the study. All of these miscarriages had abnormal morphology, based on embryoscopy findings. Developmental age was based on the crown-rump length, as reported by ultrasonography. Developmental stage was determined by embryoscopy (Moore, 2003) . Embryoscopy has been previously described in detail by Philipp et al. (2003) . Briefly, all patients were given general anaesthesia and placed in a dorsal lithotomy position. After careful dilatation of the cervix, the rigid hysteroscope (128 angle of view with both biopsy and irrigation working channel, Circon Ch 25 -8 mm) was inserted transcervically into the uterine cavity and the implantation site of the pregnancy was visualized. Continuous normal saline flow was used throughout the procedure (pressure ranging from 40 to 120 mmHg) to clean the operative field. The chorion was opened with microscissors (CH 7 -2 mm) and the embryo was initially viewed through the amnion. The amnion was then carefully opened using the microscissors to obtain a detailed view of the embryo. A complete examination of the conceptus included visualization of the head, face, dorsal and ventral walls, limbs and umbilical cord. All procedures were viewed on a TV monitor by connecting a video camera (3-CCD Colour Camera, Circon Microdigital III) to the eyepiece of the endoscope. The embryos were assigned into three categories, based on embryoscopy: (i) growth-disorganization, (ii) multiple external defects and, (iii) an isolated external defect. Growth-disorganized embryos were further subcategorized, based on their degree of disorganization (Poland et al., 1981) . For example, GD1 indicated an empty sac, GD2 indicated a nodular embryo, consisting of a chorionic sac containing solid embryonic tissue measuring 1 -4 mm in length, GD3 indicated a cylindrical embryo of up to 10 mm in length with retinal pigment and no other landmarks, and, GD4 indicated a stunted embryo with a length of .10 mm with major distortion of the embryo.
Chorionic villi were either obtained by curettage (11 cases) or direct chorion biopsies were taken embryoscopically (seven cases) at the end of the morphologic examination. Direct chorionic villus sampling was performed under visual monitoring using a microforceps. Miscarriage 3 (Table I ) was a bichorionic, biamniotic twin pregnancy and the two chorionic sacs were biopsied separately (sufficient tissue for DNA extraction was available from only one of the two embryos). In all cases, the chorionic villi were separated from maternal deciduas and blood clots, cultured and analysed using standard G-banding techniques. Only euploid embryos were studied using array CGH. The study was approved by the University of British Columbia Ethics Board.
Array-CGH
Genomic DNA was extracted from parental peripheral blood using PURE-GENE DNA Isolation Kit (Gentra, Minneapolis, MN, USA) and from chorionic villi using standard phenol chloroform extraction. Euploid male and female reference DNA (Promega, Madison, WI, USA) was used to match the sex of the samples studied.
Mb Resolution bacterial artificial chromosome array CGH
Bacterial artificial chromosome (BAC) array CGH was performed as previously described (Rajcan-Separovic et al., 2007) . Briefly, sample and reference DNA were hybridized to the 1-Mb BAC array (Spectral Genomics, Houston, TX, USA), using dye swap methods. Data analysis was performed using Spectralware 2 software (Spectral Genomics). Identification of clones with a significant DNA gain or loss was based on previously established cut-off values of 1.2 and 0.8, respectively (Tyson et al., 2005) .
High resolution oligonucleotide array CGH
Agilent 105 K array analysis was performed according to the protocol provided by the company (version 4.0, June 2006, Agilent Technologies, CA, USA) and reported by Fan et al. (2007) . Feature Extraction software (version 9.5.1, Agilent Technologies) rendered image analysis annotated against build NCBI 36 (human genome assembly UCSC hg18, March 2006). CNV selection was done in CGH Analytics (version 3.5.14, Agilent Technologies), using the ADM-2 algorithm (cutoff 6.0), followed by a filter to select regions with three or more adjacent probes and a minimum average log2 ratio +0.25 (Fan et al., 2007) .
CNV selection criteria
Common CNVs were defined as those detected in one or more of the miscarriages in our study that overlapped completely with CNVs detected in controls from at least two studies catalogued in the Database of Genomic Variants (http://projects.tcag.ca/variation). Unique CNVs were defined as those that showed no complete overlap with CNVs in the Database of Genomic Variants.
Custom array design and analysis
Custom Arrays were designed using eArray (Agilent technologies) and the ADM-2 algorithm as described above was used for identification of CNVs. Agilent-optimized probes were selected from the H. Sapiens (UCSC hg18) probe set and searches were done using the standard high density (HD) probe search for user defined genomic intervals. In order to select probes we used an average probe space filter (in the program) to select probes within our region of interest. Depending on the density of probes within a region the filter could return an average lower or higher than requested. All probes from these searches were accepted in our design. To query CNVs smaller than 100 kb, the entire CNV plus an additional 25 kb on either side of the CNV was filtered at an average probe spacing of 100 bp. A further extension of 100 kb on either side of this area was filtered at an average probe spacing of 1000 bp. To query CNVs larger than 100 kb, the CNV area was decreased on either side of the breakpoint reported by the whole genome array by 25 kb and was filtered at an average probe spacing of 200 bp. A breakpoint area was 50 kb (25 kb on either side of the CNV breakpoint) and was filtered at an average probe spacing of 100 bp. A further extension of 100 kb on either side of the breakpoints was filtered at an average probe spacing of 1000 bp.
Results
Embryoscopy
External developmental defects detected by embryoscopy for the 17 euploid miscarriages are shown in Table I . Seven of the embryos had growth disorganization, nine embryos had multiple external defects and one had an isolated external defect. Eight of the nine embryos with multiple external defects demonstrated abnormal brain development, of which six consisted of microcephaly. Figure 1 illustrates an example of each category; growth disorganization, multiple and isolated external developmental defects.
Whole genome array CGH
Genomic screening using the 1 Mb array CGH was performed on 14 of the euploid miscarriages; no unique CNVs were found (Table I ). One or two common CNVs were found per miscarriage. High resolution (0.02 Mb) Agilent array CGH (105 K) was used on seven of these euploid miscarriages, in addition to another three euploid cases (Table I) ; only cases for which parental DNA was available were studied by higher resolution array. Six to twelve common CNVs were found in each of these miscarriages, using the Agilent array CGH. Six unique CNVs, all ,250 kb, were detected in five embryos (Table II) . In order to determine the origin of the unique CNVs, parental DNA was also studied using the high resolution whole genome array analysis.
A de novo CNV was noted in embryo 4 and 1 at 13q32.1 and 10p15.3, respectively ( Fig. 2a and b) . Embryo 4 had multiple external defects ( Fig. 1c and d) , whereas embryo 1 showed growth disorganization GD1. Inherited CNVs were detected in GD1 embryo 3 at Xq28 and 1q25.3 (Fig. 2c) , and embryo 5 (at 7p14.3) which had a focal external defect (Fig. 1e and f) . GD3 embryo 2 (Fig. 1a and b) had a unique CNV (at 17p13.1, Fig. 2d ) of unknown origin. The origin of the last CNV could not be determined as, unfortunately, maternal DNA was not sufficient for analysis and blood re-sampling was not possible. All of these CNVs were submicroscopic genomic gains except CNVs at 7p14.3 and 1q25.3 which were submicroscopic deletions. The gene content for unique CNVs and their function is provided in Table II and discussed in detail in the Discussion section.
Custom array analysis of unique CNVs
Unique CNVs (Table II) were further confirmed using custom array technology. Comparison of CNV size determined by whole genome and custom array showed significant difference for the de novo CNV 13q32.1 in embryo 4 (Fig. 2a) . This CNV was almost 10 times smaller on the custom array in comparison to the whole genome array (1.5 versus 12 kb). Reduction in the size of the CNV as the resolution of the array increases was previously noted (Perry et al., 2008) . In case of embryo 4, this discrepancy may be due to the fact that the whole genome array showed a significant shift of four values within this CNV, however, on closer inspection three values were replicates for one probe, so in fact there were two independent probes from the 12 kb area that showed a shift on the whole genome array. Therefore, the size of the CNV was likely overestimated due to poor coverage. The custom array identified a 1.5 kb shift which included 44 probes (Fig. 2a) .
For the de novo CNV at 10p15.3 in embryo 1, two small area of genomic gain of 116 and 153 bp were detected with the custom array, in contrast to a continuous genomic gain of 198 kb, as detected by the whole genome array (Fig. 2b) . The 198 kb CNV contained 13 probes, however, only 7/13 had a value above the cut-off. As the values for probes are averaged for blocks of three probes, this 198 kb region was still identified as a gain by the software, but is likely overestimated in size. Copy number changes for the two small CNVs on 10p15.3 were identified by both the custom and whole genome array, unfortunately, insufficient DNA from this embryo prevented their further confirmation and analysis. Therefore, the 116 and 153 bp gains were considered putative de novo CNVs only. The more distal of the two CNVs from 10p15.3 disrupts the WDR37 gene. The proximal 153 bp CNV does not appear to contain genes. The size of the unique CNVs detected by the whole genome and custom array were comparable in embryos 2 and 3 and ranged between 31 and 213 kb. were comparable between the carrier parent and the embryo when analysed using the custom array.
Discussion
The whole genome array analysis of 17 euploid miscarriages with abnormal morphology showed that 0/17 euploid miscarriages had unique CNVs over 1 Mb in size, but 5/10 euploid miscarriages had six small unique CNVs detectable by high resolution array. These six unique CNVs were of de novo, inherited or unknown origin. A de novo CNV is usually considered pathogenic, whereas an inherited CNV from an unaffected parent is usually considered benign. However, an inherited CNV could be causative through epigenetic factors, variable expression or unmasking of recessive alleles (Lee et al., 2007) , resulting in expression in the pregnancy but not in the parent. Therefore, the genetic content of both the unique de novo and unique inherited CNVs detected in this study is discussed.
The de novo CNV at 13q32.1, found in embryo 4 with multiple focal defects, disrupted GPR180 a gene involved in vascular remodelling (Iida et al., 2003) . The gene is expressed highly during vascular smooth muscle cells multiplications and also in all adult human tissues (Iida et al., 2003) . In the murine model, the deletion of GPR180 gene did not show any obvious phenotypic effect (Iida et al., 2003) , except poor response to vascular injury.
Another putative de novo CNV, 10p15.3, disrupted WDR37 in embryo 1 (GD1 stage). This gene belongs to a family of genes which encode a large family of proteins with four or more repeat units of a conserved core of 40 amino acids usually ending with tryptophan-aspartic acid (WD). WD repeat genes have critical roles in essential biological functions, such as signal transduction, transcription regulation, apoptosis, chromatin assembly, cell cycle regulation and vesicular trafficking (Li and Roberts, 2001 ). Interestingly, a different gene of the same family (WDR16) was contained in the 17p13.1 CNV, detected in embryo 2 (GD3 stage). Unfortunately, follow-up to determine the origin of this CNV was not possible, because there was not sufficient maternal DNA left due to maternal unavailability. WDR genes have been associated with developmental abnormalities and autosomal recessive human diseases [e.g. Cockayne syndrome and Allgrove syndrome (Li and Roberts, 2001) ]. Decreased WDR16 expression has been associated with hydrocephalus in zebra fish embryos (Hirschner et al., 2007) .
The CNV at 17p13.1 in embryo 2 also disrupted the STX8 gene, which belongs to the syntaxin family of genes. Another syntaxin gene (syntaxin 6) was disrupted due to an inherited 1q25.3 CNV, found in embryo 3 (GD1 stage). Syntaxin 8 and 6 are involved in transGolgi network of endosome transport and fusion; their dysfunction may lead to cell death (Teng et al., 2001) . A recent study of syntaxin 6 gene showed that its knockdown leads to decreased cell line proliferation and survival, by inhibiting cell adhesion (Zhang et al., 2008) , a process important in embryonic development. Other genes in the syntaxin family are required for early human development; for example, syntaxin 1A gene has been found to be required for in utero mouse development and sea urchin embryogenesis (Conner and Wessel, 2001; McRory et al., 2008) . Embryo 3 also had a paternally-inherited CNV at Xq28. This unique duplication contains an intact copy of NSDH2, a gene involved in steroid biosynthesis.
Deletions of NSDH2 have been associated with male embryo lethality and placental abnormality (Jiang and Herman, 2006) . In addition, this Xq28 CNV contained the centrin 2 gene, which is required for duplication of centrioles during S phase and their separation in mitosis (Higginbotham et al., 2004) . Centrin 2 also contributes to nuclear and cytoplasmic pore complexes; misexpression results in defects of nuclear export and over-accumulation of mRNA and proteins (Resendes et al., 2008) . This paternally derived CNV is intriguing since functional centrosome of the fertilized oocyte is paternally derived (Sathananthan, 1997) . It was proposed previously that the absence and alteration of centrosomes may result in embryonic miscarriage or infertility (Rawe et al., 2002; Gil Villa et al., 2007) . Therefore, the transmission of the paternal centrosome and CNV involving centrin 2 may have caused centrosome dysfunction resulting in embryo growth disorganization and subsequent demise.
Embryo 5 had a maternally-inherited deletion at 7p14.3. This deletion disrupted the PTHB1 (BBS9) gene implicated as one of the Biedel-Bartel syndrome (BBS) associated genes (Nishimura et al., 2005) . BBS is an autosomal recessive, genetically heterogeneous, pleiotropic human disorder, characterized by obesity, retinopathy, polydactyly, renal and cardiac malformations, learning disabilities; it is also associated with premature ovarian failure (Kang et al., 2008) and ovarian abnormalities (Slavotinek et al., 2000) . The euploid embryo 5 had an isolated external defect (loss of one finger, Fig. 1 ) and the mother was phenotypically normal, therefore, this CNV may be of no significance, may have variable penetrance, or there may be a mutation on the intact allele in the embryo.
In summary, this study is the first to describe higher resolution whole genome analysis of euploid embryonic miscarriages with morphological abnormalities, identified with embryoscopy. Although the number of cases reported is small, unique CNVs were found in 29% of all cases or 50% of cases assessed using high resolution array CGH. The frequency of de novo CNVs detected (6-12%) is comparable to the rate of submicroscopic changes in other array CGH studies of euploid miscarriages (Schaeffer et al., 2004; Shimokawa et al., 2006) , although in previous studies, the origin of the CNVs was not determined, the precise genomic size, position or genetic content of the CNVs was not reported or discussed and embryoscopy was not performed. It should be noted that paternity testing was not performed out of sensitivity to the patient circumstances. Genomic screening for submicroscopic changes in euploid foetuses of greater than 15 weeks of gestation, with structural and developmental defects documented by ultrasound or routine pathology, after elective termination, showed a similar frequency (1.3 -8%) of de novo CNVs (Le Caignec et al., 2005; Shaffer et al., 2008) . Therefore, the cause of prenatally detected external developmental defects remains unknown for the majority of euploid cases. On the basis of our study the severity of the developmental defects in euploid embryos could not be associated with the presence of unique CNVs as they occurred both in growth disorganized embryos (three embryos) as well as in those with single or multiple external defects (two embryos). Other factors such as infection, maternal nutrition or medication considered to be associated with early embryonic demise (Kalousek, 2001 ) may also lead to developmental defects.
It is intriguing to note that the developmental defects in euploid and non-euploid embryonic miscarriages are comparable. It is possible that environmental factors may be responsible for a portion of euploid embryonic miscarriages, based on the report that aneuploid yeast shows a transcriptional response similar to that described in yeast cells grown under different stress conditions (Ambartsumyan and Clark, 2008) . In this respect, it is interesting to note that the STX6 gene, discussed above, was suggested to counter the activation of apoptotic pathways caused by stress signals such as lack of nutrients and damages to microenvironments (Zhang et al., 2008) . CNVs involving STX6 thus may represent predisposing factors for embryonic death.
In conclusion, this study has shown that whole genome screening of euploid embryonic miscarriages with external developmental defects, as documented by embryoscopy, identified potential pathogenic submicroscopic chromosome abnormalities, not detected by conventional cytogenetic analysis, in 6-12% of cases. The role of previously unreported but inherited CNVs remains uncertain, however, the recurrence of alteration of genes belonging to same families (syntaxin and WDR) in more than one miscarriage is of interest and may warrant further studies of their expression during early human and mammalian development.
We did not detect de novo CNVs bigger than 1 Mb in the studied embryos with developmental defects, however, further studies of additional cases, which will include parental origin of the CNV, are needed to determine the size distribution of de novo CNVs in this clinical group. Comparison of the de novo CNV size and frequency between the embryonic and post-natal cases with developmental defects would be of interest considering that de novo CNVs . 1 Mb seem to be predominant in the post-natal group (de Vries et al., 2005) . De novo CNVs appear to be slightly less frequent in the embryonic vs. post-natal group [9 versus 8-17% (Edelmann and Hirschhorn, 2009) ].
Although our initial findings suggest that developmental abnormalities in euploid embryonic miscarriages are not likely due to CNVs in the majority of cases, the more widespread genomic screening of embryonic miscarriages with external developmental defects using higher resolution array CGH may provide an opportunity to identify miscarriage genes, whose function is essential in early human development.
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